跳至主要内容
临床试验/NCT04011163
NCT04011163进行中(未招募)2 期

Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain

KK Women's and Children's Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年3月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
40
试验地点
1
主要终点
Incidence of a clinically significant bradypnoea

研究概览

简要总结

To meet the unmet need of better and safer pain relief for acute pain in the post-operative setting, a Vital-signs-integrated Patient-assisted Intravenous opioid Analgesia ("VPIA") Delivery System, with novel and intelligent software algorithms and specialised hardware was developed. In the previous project, the investigators have shown that this system has the potential to increase the safety and patient satisfaction with intravenous opioid analgesia. However, opportunities to develop more robust vital signs monitoring with the goal of ensuring continual and effective analgesia are identified.

The primary aim of this proposal is to advance the development of technology (through new features and functionality) and perform clinical evaluation of the VPIA system with a larger sample size to show improvements in patient's satisfaction (pain relief) and robustness of system in terms of vital signs integration. Novel technology using adaptive vital signs controller, integrated with an infusion pump and single finger probe vital signs monitor system will be developed with the aim for commercialisation.

详细描述

The investigators will conduct a prospective cohort study in 150 adult female subjects that undergo major surgery that require postoperative patient controlled morphine analgesia so as to examine the monitoring performance of oxygen desaturation, respiratory depression and patient satisfaction and user feedback.

Patients who are undergoing elective surgery with plan to use postoperative patient controlled analgesia with morphine will receive study information either at pre-operative assessment clinic or upon admission for surgery if they have not attended the pre-operative assessment clinic. They will be screened for eligibility using the inclusion and exclusion criteria. If eligible for recruitment, the patients will be approached by the investigators for recruitment. Upon successful recruitment of the study, patients will be asked to complete two questionnaires and rate their pre-surgical pain on the numerical rating scale in the pre-anaesthetic evaluation clinic. The general anaesthesia technique and type of analgesia administered intra-operatively will be according to standard practice and is at the discretion of the attending anaesthesiologist. After surgery, patients will be reviewed daily (up to 3 days) in the post-operative wards. They will be asked on questionnaire scoring, pain score, and analgesia information and adverse event, if any.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •American Society of Anaesthesiologist (ASA) physical status I-III;
  • •Age 21-70 years;
  • •Receiving patient controlled analgesia of morphine for postoperative analgesia.

排除标准

  • •Allergy to study drug;
  • •With significant respiratory disease and obstructive sleep apnea;
  • •Unwilling to place oxygen saturation and respiratory rate monitoring during study period;
  • •Unable to comprehend the use of patient controlled analgesia;
  • •Obstetric patients.

研究组 & 干预措施

VPIA analgesia

Experimental

VPIA pump will be connected to patients after surgery for up to three days. The vital signs (oxygen saturation, respiratory rate, heart rate) will be closely monitored when patients are using VPIA pump. Intravenous medication (morphine) will be given intravenously.

干预措施: VPIA pump (Device)

VPIA analgesia

Experimental

VPIA pump will be connected to patients after surgery for up to three days. The vital signs (oxygen saturation, respiratory rate, heart rate) will be closely monitored when patients are using VPIA pump. Intravenous medication (morphine) will be given intravenously.

干预措施: Morphine (Drug)

结局指标

主要结局

Incidence of a clinically significant bradypnoea

时间窗: Postoperative period (1 - 3 days)

The number of events of respiratory rate less than 8 per minute throughout the study period (when the patient is connected to the pump)

次要结局

  • Patient satisfaction(Postoperative period (1 day, after the use of pump))
  • EQ-5D-3L score(Before surgery (1 day))
  • Postoperative pain score(Postoperative period (1 - 3 days))
  • Changes in Hospital Anxiety and Depression Scale (HADS) score(Before surgery (1 day) and postoperative period (1-3 days))

研究者

发起方
KK Women's and Children's Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Sng Ban Leong

Principal Investigator

KK Women's and Children's Hospital

研究点 (1)

Loading locations...

相似试验